GUIDELINES
Abstract Structure
-
Abstracts should be no longer than one A4 page in portrait layout
-
The title of the abstract should be as concise as possible and should appear in bold, lower case and centred
-
Co-authors and affiliations below the title in italics (the main author's name should be underlined, and the name of the presenting author should be marked with an asterisk (*)
-
Abstract must be written in English and content should have a maximum of 300 words
-
Main body of text to be left aligned
-
Single spacing throughout
-
References, denoted by superscript numbers in the text, should be listed at the end of the text using standard Chemical Abstracts Source Service Index terminology followed by YEAR, VOLUME, and PAGE
-
The use of figures, graphs and schemes is recommended where this aids the understanding of the text
-
Abstracts should be sent as an MS Word or PDF email attachment to Conference mail id with the subject line 'CONFERENCE NAME abstract' or you can submit online via the conference website.
-
Please include your full address and contact details of the main author and the presenting author in the email and indicate whether you are submitting an oral or a poster presentation
-
Please note there is a 1MB limit for online abstract submission. If your abstract is larger, reduce the file size of your document by compressing the images. If the file size is still greater than 1MB please email without the attachment and we will reply with an email address to which you will be able to send the abstract.
-
After completion of conference, speakers could submit their full length papers to any of our related journals and will be published within 2 months of time period.
-
A confirmation mail will be sent in regards of receiving your abstract and if no mail has been received within one week, please contact the conference coordinator.
The Conference offers two options for abstract submission:
Option-1
Suited for research conducted in all disciplines. Check a sample abstract for this option here. Abstracts submitted under the first option should contain concise statements of:
Background: Indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analysed or evaluated.
Methods: Describe the study period / setting / location, study design, study population, data collection and methods of analysis used.
Results: Present as clearly and in as much detail as possible the findings / outcome of the study. Please summarize any specific results.
Conclusions: Explain the significance of your findings / outcomes of the study for HIV prevention, treatment, care and / or support, and future implications of the results.
The following review criteria wiil be used in scrooling abstracts submitted under option1:
-
Is there a clear background and justified objective?
-
Is the methodology/study design appropriate for the objectives?
-
Are the results important and clearly presented?
-
Are the conclusions supported by the results?
-
Is the study original, and does it contribute to the field?
Option-2
Suited for lessons learned through programme implementation, project or policy implementation or management. Abstracts submitted under the second option should contain concise statements of:
Background: Summarize the purpose, scope and objectives, of the programme, project or policy.
Methods: Describe the programme, project or policy period / setting / location, the structure, key population (if applicable), activities and interventions undertaken in support of the programme, project or policy.
Lessons learned: Present as clearly and in as much detail as possible the methods / findings / outcomes of the programme, project or policy; include analytic approaches, evaluation of lessons learned and best practices with a succinct description of the methods used. In addition, please summarize any specific results that specifically support your conclusions of lessons learned and best practices.
Conclusions/Nextsteps: Explain the significance of the methods used and findings / outcomes of the programme, project or policy for HIV prevention, treatment, care and / or support, and future implications of the results.
PEER-REVIEW PROCESS
All submitted abstracts will go through a peer review process carried out by a peer review committee. After successful review of your abstract, we will guide you further steps towards your presence at our event.